Description
+ Include: 3 videos + 3 file sub vtt + 1 pdf, size: 49.1 GB
+ Target Audience: cardiologists, endocrinologists, primary care physicians
+ Sample video: contact me for sample video
+ Information:
The Continuing Education Company 28th Annual Hypertension, Diabetes, & Dyslipidemia Conference 2024 offers a comprehensive clinical update on the prevention, diagnosis, and management of these three interrelated metabolic and cardiovascular risk factors. The program emphasizes evidence-based strategies, updated treatment guidelines, and multidisciplinary approaches to reduce cardiovascular morbidity and optimize long-term patient outcomes in primary care.
Course Date: Charleston, SC, from June 19-21, 2024
Explore the flavors, sights, sounds and traditions that define Charleston’s heart and soul at the 28th Annual Hypertension, Diabetes, & Dyslipidemia Conference, set against the backdrop of enchanting Charleston, SC, from June 19-21, 2024. Join fellow healthcare professionals at the Charleston Gaillard Center for a transformative, surrounded by the city’s historic charm, vibrant culture, and unmatched southern hospitality.
2. Learning Objectives
As a result of this educational activity, participants should be better able to:
- Formulate an efficient and effective assessment and monitoring plan of a patient’s condition as it relates to hypertension, diabetes, and dyslipidemia.
- Utilize current guidelines in the diagnosis and management of diabetes, hypertension, and dyslipidemia.
- Develop individualized interventions and treatment strategies for patients presenting with hypertension, diabetes, and/or dyslipidemia that will translate into improved long-term outcomes.
3. Target Audience
Best for primary care providers who want updates on managing hypertension, diabetes, and dyslipidemia.
This conference is designed for physicians, nurse practitioners, physician assistants, and other related health care professionals specializing in areas of geriatric medicine, endocrinology, lipidology and/or hypertension along with those managing patients with hypertension, diabetes, and/or hyperlipidemia.
4. Topics
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
- Day 1 – June 19, 2024
- Day 2 – June 20, 2024
- Day 3 – June 21, 2024
+ Topics:
- WEDNESDAY, June 19, 2024 Day 1: Focus on Diabetes
- 7:50 am – 8:00 am Welcome W. Ejnes, CHCP
- 8:00 am – 8:45 am Effect of Glucose-lowering Drugs on Cardiovascular Events in People with T2DM – Evidence from RCTs H. Gerstein, MD
- 8:45 am – 9:30 am Standards of Care: The Non-Glycemic Targets for Cardio-Metabolic Improvement Contrasting the ADA, AACE, AHA, and EASD/ESC T. Garvey, MD
- 9:30 am – 10:15 am Growing Benefits & Promise of GLP-1 RA, GIP-GLP-1 Co-agonists & Related Drugs on Vascular Outcomes in T2DM – Evidence from RCTs H. Gerstein, MD
- 10:15 am BREAK
- 10:30 am – 11:15 am Obesity as a Chronic Disease: Current and Future Approaches T. Garvey, MD
- 11:15 am – 11:30 am Questions for the Faculty H. Gerstein, MD & T. Garvey, MD
- 11:30 am – 12:45 pm Cases in Diabetes and Cardiometabolic Disease H. Gerstein, MD & T. Garvey, MD
- THURSDAY, June 20, 2024 Day 2: Focus on Hypertension
- 7:40 am – 7:45 am Welcome W. Ejnes, CHCP
- 7:45 am – 8:00 am Day One Review of Key Points J. Basile, MD
- 8:00 am – 9:00 am What’s New in Resistant Hypertension J. Basile, MD
- 9:00 am – 9:45 am Primary Aldosteronism: Tips for the Clinician W. Young, MD
- 9:45 am – 10:30 am An Evidence-Based Approach for Treatment of CKD in People With and Without Diabetes M. Weir, MD
- 10:30 am BREAK
- 10:45 am – 11:30 am Update on Pheochromocytma and Adrenal Incidentaloma W. Young, MD
- 11:30 am – 12:15 pm New Approaches to Reducing Mineralocorticoid Receptor Activity; Will Outcomes Justify Cost M. Weir, MD
- 12:15 pm – 12:30 pm Questions for the Faculty J. Basile, MD, W. Young, MD, & M. Weir, MD
- 12:30 pm LUNCH BREAK (Working Lunch)
- 12:45 pm – 2:15 pm Hypertension Cases J. Cohen, MD & Faculty Panel
- FRIDAY, June 21, 2024 Day 3: Focus on Dyslipidemia
- 7:40 am – 7:45 am Welcome W. Ejnes, CHCP
- 7:45 am – 8:00 am Day Two Review of Key Points J. Basile, MD
- 8:00 am – 8:45 am Update on LDL-C Management: Lower Targets and New Tools to Get There P. Taub, MD
- 8:45 am – 9:30 am Lipoprotein (a): Current and Emerging Therapies to Decrease Cardiovascular Risk E. Michos, MD
- 9:30 am – 10:15 am New Understanding in the Management of Triglycerides and HDL-Cholesterol P. Taub, MD
- 10:15 am BREAK
- 10:30 am – 11:15 am Lipids in Women Across the Lifespan E. Michos, MD
- 11:15 am – 11:30 am Questions for the Faculty P. Taub, MD & E.Michos, MD
- 11:30 am – 12:45 pm Lipid Cases P. Taub, MD & E.Michos, MD
Reviews
There are no reviews yet.